Testosterone, TMPRSS2, and aromatase were independently associated (p < 0.01) with severity after adjusting for several baseline risk variables (including age, sex, CRP, obesity, hypertension, hyperlipidemia, and diabetes) in a multivariate logistic regression model (Table 2). Here, CYP19A1 is linked to hyperlipidemia.